BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23684609)

  • 1. Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo.
    Sharma P; Yamada S; Lualdi M; Dasso M; Kuehn MR
    Cell Rep; 2013 May; 3(5):1640-50. PubMed ID: 23684609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and paralogue specificity of mammalian deSUMOylating enzymes.
    Kolli N; Mikolajczyk J; Drag M; Mukhopadhyay D; Moffatt N; Dasso M; Salvesen G; Wilkinson KD
    Biochem J; 2010 Sep; 430(2):335-44. PubMed ID: 20590526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonic Cells Redistribute SUMO1 upon Forced SUMO1 Overexpression.
    Lee A; Zhu Y; Sabo Y; Goff SP
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7.
    Lima CD; Reverter D
    J Biol Chem; 2008 Nov; 283(46):32045-55. PubMed ID: 18799455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.
    Fasci D; Anania VG; Lill JR; Salvesen GS
    Sci Signal; 2015 Jun; 8(380):ra56. PubMed ID: 26060329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SUMO-specific protease SENP1 deSUMOylates p53 and regulates its activity.
    Chauhan KM; Chen Y; Chen Y; Liu AT; Sun XX; Dai MS
    J Cell Biochem; 2021 Feb; 122(2):189-197. PubMed ID: 32786121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The requirement of SUMO2/3 for SENP2 mediated extraembryonic and embryonic development.
    Yu HI; Hsu T; Maruyama EO; Paschen W; Yang W; Hsu W
    Dev Dyn; 2020 Feb; 249(2):237-244. PubMed ID: 31625212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development.
    Wang L; Wansleeben C; Zhao S; Miao P; Paschen W; Yang W
    EMBO Rep; 2014 Aug; 15(8):878-85. PubMed ID: 24891386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.
    Evdokimov E; Sharma P; Lockett SJ; Lualdi M; Kuehn MR
    J Cell Sci; 2008 Dec; 121(Pt 24):4106-13. PubMed ID: 19033381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swapping small ubiquitin-like modifier (SUMO) isoform specificity of SUMO proteases SENP6 and SENP7.
    Alegre KO; Reverter D
    J Biol Chem; 2011 Oct; 286(41):36142-36151. PubMed ID: 21878624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO-specific proteases and isopeptidases of the SENP family at a glance.
    Kunz K; Piller T; Müller S
    J Cell Sci; 2018 Mar; 131(6):. PubMed ID: 29559551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
    Citro S; Chiocca S
    Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DeSUMOylating enzymes--SENPs.
    Drag M; Salvesen GS
    IUBMB Life; 2008 Nov; 60(11):734-42. PubMed ID: 18666185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncovalent structure of SENP1 in complex with SUMO2.
    Ambaye ND
    Acta Crystallogr F Struct Biol Commun; 2019 May; 75(Pt 5):332-339. PubMed ID: 31045562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of SENP1/SuPr-2 reveals an essential role for desumoylation in mouse development.
    Yamaguchi T; Sharma P; Athanasiou M; Kumar A; Yamada S; Kuehn MR
    Mol Cell Biol; 2005 Jun; 25(12):5171-82. PubMed ID: 15923632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The allosteric effect of the upper half of SENP1 contributes to its substrate selectivity for SUMO1 over SUMO2.
    Shi Y; Yasen M; Wang Z; Du T; Ding Y; Li X; Chai Z; Jie C; Ju G; Ji M
    J Biomol Struct Dyn; 2023; 41(21):12372-12386. PubMed ID: 36656084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the activity and substrate specificity of the human SENP family of SUMO proteases.
    Mendes AV; Grou CP; Azevedo JE; Pinto MP
    Biochim Biophys Acta; 2016 Jan; 1863(1):139-47. PubMed ID: 26522917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO paralogue-specific functions revealed through systematic analysis of human knockout cell lines and gene expression data.
    Bouchard D; Wang W; Yang WC; He S; Garcia A; Matunis MJ
    Mol Biol Cell; 2021 Sep; 32(19):1849-1866. PubMed ID: 34232706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentrin/SUMO specific proteases as novel tissue-selective modulators of vitamin D receptor-mediated signaling.
    Lee WP; Jena S; Doherty D; Ventakesh J; Schimdt J; Furmick J; Widener T; Lemau J; Jurutka PW; Thompson PD
    PLoS One; 2014; 9(2):e89506. PubMed ID: 24586832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
    Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
    Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.